Related Experiment Video

Updated: Jun 5, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Cancer: Pancreatic carcinomas metastasize at a late stage in their development

Shreeya Nanda

    Nature Reviews. Gastroenterology & Hepatology
    |January 26, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
    09:25

    Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

    Published on: June 28, 2013

    An Orthotopic Resectional Mouse Model of Pancreatic Cancer
    07:17

    An Orthotopic Resectional Mouse Model of Pancreatic Cancer

    Published on: September 24, 2020

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
    07:08

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

    Published on: February 2, 2024

    Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
    09:25

    Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

    Published on: June 28, 2013

    An Orthotopic Resectional Mouse Model of Pancreatic Cancer
    07:17

    An Orthotopic Resectional Mouse Model of Pancreatic Cancer

    Published on: September 24, 2020

    Related Concept Videos

    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

    Articles linked to this work by shared authors, journal, and citation graph.

    Retrospective analysis of the quality of reports by author-suggested and non-author-suggested reviewers in journals operating on open or single-blind peer review models.

    BMJ open·2015

    Unpublished genomic data-how to share?

    BMC genomics·2014

    Expression of concern: Subfunctionalization reduces the fitness cost of gene duplication in humans by buffering dosage imbalances.

    BMC genomics·2013

    Heart-liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework.

    Nature reviews. Gastroenterology & hepatology·2026

    Building and regenerating intestines by manipulating intestinal stem cells.

    Nature reviews. Gastroenterology & hepatology·2026

    Challenges and opportunities in combining radiotherapy and immunotherapy for localized pancreatic cancer.

    Nature reviews. Gastroenterology & hepatology·2026

    Long non-coding RNAs in colorectal cancer: shaping the tumour microenvironment and advancing precision oncology.

    Nature reviews. Gastroenterology & hepatology·2026

    Sexual dimorphism in the liver.

    Nature reviews. Gastroenterology & hepatology·2026

    Global epidemiology of metabolic and alcohol-associated liver disease: risk factors, natural history and clinical implications.

    Nature reviews. Gastroenterology & hepatology·2026

    Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.

    Drug design, development and therapy·2026

    Synchronous Low-Grade Appendiceal Mucinous Neoplasm and Neuroendocrine Tumor Presenting as Pseudomyxoma Peritonei: A Case Report.

    Cureus·2026

    Short communication: Fluorescence preservation of protoporphyrin IX in fresh frozen glioma tissue.

    Brain & spine·2026

    PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.

    Molecular therapy. Nucleic acids·2026

    A sequentially activated afterglow probe for AND-gated imaging of alpha-fetoprotein in hepatocellular carcinoma.

    Bioactive materials·2026

    miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.

    Molecular therapy. Nucleic acids·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us